For: | Wang XL, Cai HP, Ge JH, Su XF. Detection of eukaryotic translation initiation factor 4E and its clinical significance in hepatocellular carcinoma. World J Gastroenterol 2012; 18(20): 2540-2544 [PMID: 22654452 DOI: 10.3748/wjg.v18.i20.2540] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i20/2540.htm |
Number | Citing Articles |
1 |
Jun Tu, Yalan Chen, Lili Cai, Changming Xu, Yang Zhang, Yanmei Chen, Chen Zhang, Jian Zhao, Jinke Cheng, Hongwei Xie, Fan Zhong, Fuchu He. Functional Proteomics Study Reveals SUMOylation of TFII-I is Involved in Liver Cancer Cell Proliferation. Journal of Proteome Research 2015; 14(6): 2385 doi: 10.1021/acs.jproteome.5b00062
|
2 |
Shakur Mohibi, Xinbin Chen, Jin Zhang. Cancer the‘RBP’eutics–RNA-binding proteins as therapeutic targets for cancer. Pharmacology & Therapeutics 2019; 203: 107390 doi: 10.1016/j.pharmthera.2019.07.001
|
3 |
N Robichaud, S V del Rincon, B Huor, T Alain, L A Petruccelli, J Hearnden, C Goncalves, S Grotegut, C H Spruck, L Furic, O Larsson, W J Muller, W H Miller, N Sonenberg. Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3. Oncogene 2015; 34(16): 2032 doi: 10.1038/onc.2014.146
|
4 |
Christina Skofler, Florian Kleinegger, Stefanie Krassnig, Anna Maria Birkl-Toeglhofer, Georg Singer, Holger Till, Martin Benesch, Regina Cencic, John A. Porco, Jerry Pelletier, Christoph Castellani, Andrea Raicht, Ewa Izycka-Swieszewska, Piotr Czapiewski, Johannes Haybaeck. Eukaryotic Translation Initiation Factor 4AI: A Potential Novel Target in Neuroblastoma. Cells 2021; 10(2): 301 doi: 10.3390/cells10020301
|
5 |
Jennifer A. Sanders, Philip A. Gruppuso. Translation and Its Regulation in Cancer Biology and Medicine. 2014; : 611 doi: 10.1007/978-94-017-9078-9_30
|
6 |
Xuexia Li, Qiang Zhu, Xiaoliu Shi, Yaxian Cheng, Xueliu Li, Huan Xu, Xiaotao Duan, Linda C. Hsieh-Wilson, Jennifer Chu, Jerry Pelletier, Maowei Ni, Zhiguo Zheng, Sihui Li, Wen Yi. O-GlcNAcylation of core components of the translation initiation machinery regulates protein synthesis. Proceedings of the National Academy of Sciences 2019; 116(16): 7857 doi: 10.1073/pnas.1813026116
|
7 |
Yasmeen Ahmed Salaheldin, Salma Sayed Mohamed Mahmoud, Ebenezeri Erasto Ngowi, Vivian Aku Gbordzor, Tao Li, Dong-Dong Wu, Xin-Ying Ji, Kanhaiya Singh. Role of RONS and eIFs in Cancer Progression. Oxidative Medicine and Cellular Longevity 2021; 2021(1) doi: 10.1155/2021/5522054
|
8 |
Ahmed M Abdelaziz, Mingfeng Yu, Shudong Wang. Mnk Inhibitors: a Patent Review. Pharmaceutical Patent Analyst 2021; 10(1): 25 doi: 10.4155/ppa-2020-0028
|
9 |
Nehal S. Abouhashem, Amira Elwan, Noha F. Elaidy. Outcome of Patients With Head and Neck Squamous Cell Carcinoma Can be Predicted by Expression of eIF4E and Osteopontin in Free Surgical Margins. Applied Immunohistochemistry & Molecular Morphology 2022; 30(5): e40 doi: 10.1097/PAI.0000000000001017
|
10 |
Jingtao Li, Xianghui Zhang, Le Li, Jinliang Liu, Yanhua Zhang, Hongyu Pan. Proteomics Analysis of SsNsd1-Mediated Compound Appressoria Formation in Sclerotinia sclerotiorum. International Journal of Molecular Sciences 2018; 19(10): 2946 doi: 10.3390/ijms19102946
|
11 |
Mengyan Wu, Yingxia Liu, Xiaoqing Di, Haixian Kang, Hua Zeng, Yi Zhao, Kangrong Cai, Tianyun Pang, Sen Wang, Yunhong Yao, Xinrong Hu. EIF4E over-expresses and enhances cell proliferation and cell cycle progression in nasopharyngeal carcinoma. Medical Oncology 2013; 30(1) doi: 10.1007/s12032-012-0400-z
|
12 |
Takayuki Kogure, A. Douglas Kinghorn, Irene Yan, Brad Bolon, David M. Lucas, Michael R. Grever, Tushar Patel, Manlio Vinciguerra. Therapeutic Potential of the Translation Inhibitor Silvestrol in Hepatocellular Cancer. PLoS ONE 2013; 8(9): e76136 doi: 10.1371/journal.pone.0076136
|
13 |
Suzana Bracic Tomazic, Christoph Schatz, Johannes Haybaeck. Translational Regulation in Hepatocellular Carcinogenesis. Drug Design, Development and Therapy 2021; : 4359 doi: 10.2147/DDDT.S255582
|
14 |
Muhammad Umar Ali, Muhammad Saif Ur Rahman, Zhenyu Jia, Cao Jiang. Eukaryotic translation initiation factors and cancer. Tumor Biology 2017; 39(6): 101042831770980 doi: 10.1177/1010428317709805
|
15 |
Yike Yuan, Yaguang Zhang, Shaohua Yao, Huashan Shi, Xi Huang, Yuhao Li, Yuquan Wei, Shuo Lin. The Translation Initiation Factor eIF3i Up-regulates Vascular Endothelial Growth Factor A, Accelerates Cell Proliferation, and Promotes Angiogenesis in Embryonic Development and Tumorigenesis. Journal of Biological Chemistry 2014; 289(41): 28310 doi: 10.1074/jbc.M114.571356
|
16 |
Mamatha Bhat, Akiko Yanagiya, Tyson Graber, Nataliya Razumilava, Steve Bronk, Domenick Zammit, Yunhao Zhao, Chadi Zakaria, Peter Metrakos, Michael Pollak, Nahum Sonenberg, Gregory Gores, Maritza Jaramillo, Masahiro Morita, Tommy Alain. Metformin requires 4E-BPs to induce apoptosis and repress translation of Mcl-1 in hepatocellular carcinoma cells. Oncotarget 2017; 8(31): 50542 doi: 10.18632/oncotarget.10671
|
17 |
Yongdong Liu, Liling Sun, Xingwang Su, Sien Guo. Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2016; 84: 237 doi: 10.1016/j.biopha.2016.09.038
|
18 |
Nathaniel Robichaud, Nahum Sonenberg. Translation and Its Regulation in Cancer Biology and Medicine. 2014; : 73 doi: 10.1007/978-94-017-9078-9_4
|
19 |
Jun Tan, Jingfen Ye, Meijun Song, Mi Zhou, Yaoren Hu. Ribavirin augments doxorubicin's efficacy in human hepatocellular carcinoma through inhibiting doxorubicin‐induced eIF4E activation. Journal of Biochemical and Molecular Toxicology 2018; 32(1) doi: 10.1002/jbt.22007
|
20 |
Alessandra Scagliola, Annarita Miluzio, Stefano Biffo. Translational Control of Metabolism and Cell Cycle Progression in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(5): 4885 doi: 10.3390/ijms24054885
|
21 |
Xue-Mei Jiang, Xiang-Nan Yu, Ren-Zheng Huang, Hai-Rong Zhu, Xiao-Peng Chen, Ju Xiong, Zheng-Yi Chen, Xiao-Xi Huang, Xi-Zhong Shen, Ji-Min Zhu. Prognostic significance of eukaryotic initiation factor 4E in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2016; 142(11): 2309 doi: 10.1007/s00432-016-2232-2
|
22 |
Nicole Golob-Schwarzl, Stefanie Krassnig, Anna M. Toeglhofer, Young Nyun Park, Margit Gogg-Kamerer, Klemens Vierlinger, Fabian Schröder, Hyungjn Rhee, Rudolf Schicho, Peter Fickert, Johannes Haybaeck. New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors. European Journal of Cancer 2017; 83: 56 doi: 10.1016/j.ejca.2017.06.003
|
23 |
Nicole Golob-Schwarzl, Christina Wodlej, Florian Kleinegger, Margit Gogg-Kamerer, Anna Maria Birkl-Toeglhofer, Johannes Petzold, Ariane Aigelsreiter, Michael Thalhammer, Young Nyun Park, Johannes Haybaeck. Eukaryotic translation initiation factor 6 overexpression plays a major role in the translational control of gallbladder cancer. Journal of Cancer Research and Clinical Oncology 2019; 145(11): 2699 doi: 10.1007/s00432-019-03030-x
|
24 |
Chunmei Wang, Antonio Cigliano, Lijie Jiang, Xiaolei Li, Biao Fan, Maria G. Pilo, Yan Liu, Bing Gui, Marcella Sini, Jeffrey W. Smith, Frank Dombrowski, Diego F. Calvisi, Matthias Evert, Xin Chen. 4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N‐Ras proto‐oncogenes in mice. Hepatology 2015; 61(1): 200 doi: 10.1002/hep.27396
|